Noonberg Sarah B. — SEC Form 4 filings
SEC reporting owner CIK 1706301. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-18 to 2026-02-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,239 shares, $9,168 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 5,239 shares @ $1.75 ($9,168) in Metagenomi, Inc., filed 2025-06-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Metagenomi, Inc. (MGX) | Chief Medical Officer | 3 | — | 1 leg · 5,239 sh · $9,168 | 4 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) | Director | 2 | — | — | 4 |
| Neurogene Inc. (NGNE) | Director | 4 | — | — | 4 |
Form 4 filings — Noonberg Sarah B.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-24 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 12,050 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 12,050 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 5,239 @ $1.75 | EDGAR |
| 2025-04-03 | 4 | Metagenomi, Inc. (MGX) | Grant/award (A): 14,000 @ $0 · Grant/award (A): 84,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 2,300 @ $0 · Grant/award (A): 10,450 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 7,700 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Metagenomi, Inc. (MGX) | Grant/award (A): 57,763 @ $0 · Grant/award (A): 242,875 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 4,600 @ $0 · Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Neurogene Inc. (NGNE) | Grant/award (A): 15,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1706301 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →